Reflections on the quarterly report and revenue st
Post# of 721
(Total Views: 218)
Posted On: 10/16/2020 9:15:21 AM
Reflections on the quarterly report and revenue streams; Due to the pandemic of Covid-19, most businesses has been hurt, more or less. Lexarias goal (see Chris letter to shareholders, dec 2019) was a 100% increase in revenue - year to year. Though we now know it was a 70% increase on quarterly basis, it`s not to bad, giving the circumstances with the pandemic - and a 1,3 million dollars cash in the bank today.
448000 dollars (as I recall) is roughly 150000/monthly. Is close to 2 million dollars/yearly - if we assume this quarter is about a average number. It`s not a big win, though no disaster either. Giving the deals are growing yearly (especially Cannadips CBD deal), we might reach the 100% goal by next year.
The advantage Lexaria has to many other companies, is that it has diversified to 4 independent divisions = less risk for the overall company. Another is the CEOs major shareholder position; we know he is MOTIVATED to grow "his" company!
448000 dollars (as I recall) is roughly 150000/monthly. Is close to 2 million dollars/yearly - if we assume this quarter is about a average number. It`s not a big win, though no disaster either. Giving the deals are growing yearly (especially Cannadips CBD deal), we might reach the 100% goal by next year.
The advantage Lexaria has to many other companies, is that it has diversified to 4 independent divisions = less risk for the overall company. Another is the CEOs major shareholder position; we know he is MOTIVATED to grow "his" company!
(2)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Robert